Department Of Pediatric Blood & Marrow Transplant
Diane George, MD

Diane George, MD cares for children and adolescents undergoing stem cell transplantation as a treatment for cancer (particularly leukemia and lymphoma), noncancerous blood disorders (like sickle cell anemia), and immunodeficiencies. She specializes in transplantation for patients who don't have a related bone marrow donor and also takes care of patients undergoing autologous stem cell transplantation for solid tumors.

Dr. George was originally attracted to the field of pediatric oncology because she wanted to take on the challenge of fighting pediatric cancer, and stem cell transplantation offers the ultimate cure in select patients. It is a complex medical field, and Dr. George enjoys being able to take care of children with complex medical conditions.

Dr. George also conducts clinical research. She is currently evaluating a procedure called "CD34-selected stem cell transplantation" to remove T-cells from donor bone marrow. This approach reduces the risk of graft-versus-host disease (GVHD) - a potential complication of bone marrow transplantation in which T-cells from the donor attack the tissue of the recipient. This approach benefits patients who do not have a well-matched family donor, and it could potentially make bone marrow transplantation an option for more patients. Dr. George is also interested in studying how a patient's immune system rebuilds itself after CD34-selected stem cell transplantation.

At NewYork-Presbyterian/Morgan Stanley Children's Hospital, every member of a child's healthcare team shares the same compassion and dedication to helping them get well. Dr. George looks forward each day to the camaraderie, intellectual stimulation, and problem-solving she shares with fellow team members. After being in the field for more than 20 years, Dr. George uses the knowledge and experience she has gained to benefit patients and their families.

Clinical Studies Managed By This Investigator:
Condition Study Title
Cancer [ CLOSED ] CD34 Stem Cell Selection for Malignant Condition
Pediatrics [ CLOSED ] Study of Patients Receiving an Allogeneic Stem Cell Transplantation for Non-Malignant Disease
Blood Disorders [ CLOSED ] Study of Patients Receiving a Stem Cell Transplant for Non-Malignant Disease
Cancer [ CLOSED ] Study of Olanzapine in Children Receiving Chemotherapy for Hematopoietic Stem Cell Transplant (HSCT)